GlassScriptPhysician profile
Snegha Ananth
NPI 1629508817
$1,509.55
in general payments reported to CMS, 2019-2025
6 companies · $1,089 in 2025
The $1,089 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $89.00 · 2024: $332 · 2025: $1,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $794 · Food and Beverage: $626 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $794.19 |
| Food and Beverage | $626.36 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adaptive Biotechnologies Corporation | $1,032.79 | 2024-2025 | Clonoseq |
| Kite Pharma, INC. | $167.32 | 2025 | |
| Legend Biotech USA INC. | $152.42 | 2025 | Carvykti |
| Incyte Corporation | $89.00 | 2023 | |
| Epizyme, INC. | $47.00 | 2025 | Tazverik |
| Celgene Corporation | $21.02 | 2025 | Breyanzi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Snegha Ananth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.